以岭药业 engages in the research, development, and manufacture of traditional Chinese medicine, focusing on treatments for cardiovascular and respiratory conditions. The company is self-described as a pioneer in integrating modern medical science with traditional practices.

以岭药业

YILING PHARMACEUTICAL（以岭药业） | 4,716 followers on LinkedIn. Unity Progress Honesty Dedicated
团结 奋进 诚信 奉献 | Shijiazhuang Yiling Pharmaceutical Co.,Ltd. is one national level key high and new technology enterprise in China. It was founded by Professor Wu Yiling, a tutor of doctoral students in 1992.

HRM - 以岭药业

ALINA LAM

Head of HR，营销公司

Amy Zhang

佑嘉（杭州）生物医药科技有限公司副总经理

张晨光

项目策划

许源

YILING PHARMACEUTICAL（以岭药业）

Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of medicine primarily in China. The company operates through Chemical and Biological Medicine, and Health Industry segments. It offers drugs for cardiac and premature ventricular beats, sinus bradycardia, chronic heart failure, integrated rhythm regulation, cold and respiratory, cardiovascular and cerebrovascular diseases, diabetes field, tumor medication, and others. The company sells its products through physical display and online. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.

Shijiazhuang Yiling Pharmaceutical Co., Ltd.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 17, 2024 8:44 PM	55f7ecff
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 17, 2024 8:44 PM	9d7f0cba
crunchbase trigger	general	Nov 17, 2024 8:44 PM	224f26ed
crunchbase profile	general	Nov 17, 2024 9:05 PM	e9c7258e
li profile	general	Nov 17, 2024 8:44 PM	b9a26b52
translate crunchbase fundingrounds	general
peers	general	Nov 17, 2024 8:44 PM	3c674deb
news basic	general	Nov 17, 2024 8:44 PM	f42c43ae
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

0026

CN:YILING

以岭药业

Last Close

17.53

22/11 07:04

Market Cap

25.56B

Beta: -

Volume Today

15.21M

Avg: -